Search

Ban, Ehsan, Benjamin R. Freedman, Lucas Robert Smith, and Rebecca G. Wells. 2023. “Editorial: The Mechanobiology of Collagen Remodeling in Health and Disease”. Frontiers in Mechanical Engineering 9.

Najibi, Alexander J., Ryan S. Lane, Miguel C. Sobral, Benjamin R. Freedman, Joel Gutierrez Estupinan, Alberto Elosegui-Artola, Christina M. Tringides, et al. 2022. “Lymph Node Expansion Predicts Magnitude of Vaccine Immune Response”. BioRxiv.

Driscoll, Adam. 2020. Lorem Ipsum Dolor Sit Amet, Consectetur Adipiscing Elit, Sed Do Eiusmod Tempor Incididunt Ut Labore et Dolore Magna Aliqua.. Publihser’s Name.

Tan, Kemin, and Jack Lawler. 2009. “The Interaction of Thrombospondins With Extracellular Matrix Proteins.”. Journal of Cell Communication and Signaling 3 (3-4): 177-87.

Ren, Bin, Keli Song, Sareh Parangi, Taiguang Jin, Min Ye, Robin Humphreys, Mark Duquette, et al. 2009. “A Double Hit to Kill Tumor and Endothelial Cells by TRAIL and Antiangiogenic 3TSR.”. Cancer Research 69 (9): 3856-65.

Yee, Karen O, Caitlin M Connolly, Mark Duquette, Shideh Kazerounian, Raymond Washington, and Jack Lawler. 2009. “The Effect of Thrombospondin-1 on Breast Cancer Metastasis.”. Breast Cancer Research and Treatment 114 (1): 85-96.

Ali, Naeem A, Alice A Gaughan, Charles G Orosz, Chris P Baran, Sara McMaken, Yijie Wang, Timothy D Eubank, et al. 2008. “Latency Associated Peptide Has in Vitro and in Vivo Immune Effects Independent of TGF-Beta1.”. PloS One 3 (4): e1914.

Tan, Kemin, Mark Duquette, Jin-huan Liu, Kumaran Shanmugasundaram, Andrzej Joachimiak, John T Gallagher, Alan C Rigby, Jia-huai Wang, and Jack Lawler. 2008. “Heparin-Induced Cis- and Trans-Dimerization Modes of the Thrombospondin-1 N-Terminal Domain.”. The Journal of Biological Chemistry 283 (7): 3932-41.

Zhang, Xuefeng, and Jack Lawler. 2007. “Thrombospondin-Based Antiangiogenic Therapy.”. Microvascular Research 74 (2-3): 90-9.

Zwicker, Jeffrey I, Flora Peyvandi, Roberta Palla, Rossana Lombardi, Maria Teresa Canciani, Andrea Cairo, Diego Ardissino, et al. 2006. “The Thrombospondin-1 N700S Polymorphism Is Associated With Early Myocardial Infarction Without Altering Von Willebrand Factor Multimer Size.”. Blood 108 (4): 1280-3.